Distinct types of lung disease caused by functional subsets of antiviral T cells

doi:10.1084/jem.179.1.81

This Article

Full Text (PDF, 939K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Alwan, W. H.

Articles by Openshaw, P. J.

Search for Related Content

PubMed

PubMed Citation

Articles by Alwan, W. H.

Articles by Openshaw, P. J.

Pubmed/NCBI databases

Medline Plus Health Information
Lung Diseases

Social Bookmarking

What's this?

ARTICLES

Distinct types of lung disease caused by functional subsets of antiviral T cells

WH Alwan, WJ Kozlowska and PJ Openshaw
Department of Medicine, Imperial College of Science, Technology and Medicine, London, UK.

T cells appear to play a central role in viral bronchiolitis, but the effects of different functional and phenotypic subgroups of T cells have not been defined. To test the activities of T cells recognizing individual proteins of respiratory syncytial (RS) virus, virus-specific T cell lines were produced from mice primed by scarification with recombinant vaccinia viruses expressing the major surface glycoprotein (G), fusion protein (F) or second matrix (22K) protein of RS virus. As previously reported, the in vitro characteristics of these cells are predetermined by the choice of RS virus protein: 22K-specific cells are predominantly class I-restricted cytolytic CD8+ cells; F-specific cells, a mixture of cytolytic CD8+ cells and CD4+ cells with a T helper 1 cell (Th1) cytokine secretion profile, whereas those from G- sensitized mice are almost exclusively CD4+, with Th2 characteristics. Mice infected intranasally with RS virus showed mild illness and recovered fully, but developed respiratory distress after intravenous injections of T cells. Dose-for-dose, infected mice receiving G- specific cells suffered the most severe (sometimes fatal) illness, characterized by lung hemorrhage, pulmonary neutrophil recruitment (shock lung) and intense pulmonary eosinophilia. This disease was further enhanced by coinjection of 22K-specific cells, which alone caused mild shock lung without eosinophilia. F-specific cells caused minimal enhancement of pathology and had little or no effect on the disease caused by G-specific cells. Each cell line reduced lung virus titer and combined injections of G- and 22K-specific cells eliminated infection completely. The in vitro characteristics of these antiviral T cell lines therefore predict the pathological effects in vivo. Moreover, different forms of viral bronchiolitis can be caused by functionally distinct types of activated T cell.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Dodd, J., Riffault, S., Kodituwakku, J. S., Hayday, A. C., Openshaw, P. J. M. (2009). Pulmonary V{gamma}4+ {gamma}{delta} T Cells Have Proinflammatory and Antiviral Effects in Viral Lung Disease. J. Immunol. 182: 1174-1181 [Abstract] [Full Text]
Johnson, T. R., Rothenberg, M. E., Graham, B. S. (2008). Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein. J. Leukoc. Biol. 84: 748-759 [Abstract] [Full Text]
Castilow, E. M., Olson, M. R., Meyerholz, D. K., Varga, S. M. (2008). Differential Role of Gamma Interferon in Inhibiting Pulmonary Eosinophilia and Exacerbating Systemic Disease in Fusion Protein-Immunized Mice Undergoing Challenge Infection with Respiratory Syncytial Virus. J. Virol. 82: 2196-2207 [Abstract] [Full Text]
Wissinger, E. L., Stevens, W. W., Varga, S. M., Braciale, T. J. (2008). Proliferative Expansion and Acquisition of Effector Activity by Memory CD4+ T Cells in the Lungs following Pulmonary Virus Infection. J. Immunol. 180: 2957-2966 [Abstract] [Full Text]
Mok, H., Lee, S., Utley, T. J., Shepherd, B. E., Polosukhin, V. V., Collier, M. L., Davis, N. L., Johnston, R. E., Crowe, J. E. Jr. (2007). Venezuelan Equine Encephalitis Virus Replicon Particles Encoding Respiratory Syncytial Virus Surface Glycoproteins Induce Protective Mucosal Responses in Mice and Cotton Rats. J. Virol. 81: 13710-13722 [Abstract] [Full Text]
Heidema, J., Lukens, M. V., van Maren, W. W. C., van Dijk, M. E. A., Otten, H. G., van Vught, A. J., van der Werff, D. B. M., van Gestel, S. J. P., Semple, M. G., Smyth, R. L., Kimpen, J. L. L., van Bleek, G. M. (2007). CD8+ T Cell Responses in Bronchoalveolar Lavage Fluid and Peripheral Blood Mononuclear Cells of Infants with Severe Primary Respiratory Syncytial Virus Infections. J. Immunol. 179: 8410-8417 [Abstract] [Full Text]
Olson, M. R., Varga, S. M. (2007). CD8 T Cells Inhibit Respiratory Syncytial Virus (RSV) Vaccine-Enhanced Disease. J. Immunol. 179: 5415-5424 [Abstract] [Full Text]
Culley, F. J., Pennycook, A. M. J., Tregoning, J. S., Hussell, T., Openshaw, P. J. M. (2006). Differential Chemokine Expression following Respiratory Virus Infection Reflects Th1- or Th2-Biased Immunopathology. J. Virol. 80: 4521-4527 [Abstract] [Full Text]
Marodi, L. (2006). Neonatal Innate Immunity to Infectious Agents. Infect. Immun. 74: 1999-2006 [Full Text]
Bukreyev, A., Belyakov, I. M., Prince, G. A., Yim, K. C., Harris, K. K., Berzofsky, J. A., Collins, P. L. (2005). Expression of Interleukin-4 by Recombinant Respiratory Syncytial Virus Is Associated with Accelerated Inflammation and a Nonfunctional Cytotoxic T-Lymphocyte Response following Primary Infection but Not following Challenge with Wild-Type Virus. J. Virol. 79: 9515-9526 [Abstract] [Full Text]
Openshaw, P. J. M. (2005). Antiviral Immune Responses and Lung Inflammation after Respiratory Syncytial Virus Infection. Proc Am Thorac Soc 2: 121-125 [Abstract] [Full Text]
Tripp, R. A., Oshansky, C., Alvarez, R. (2005). Cytokines and Respiratory Syncytial Virus Infection. Proc Am Thorac Soc 2: 147-149 [Abstract] [Full Text]
Openshaw, P. J. M., Tregoning, J. S. (2005). Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection. Clin. Microbiol. Rev. 18: 541-555 [Abstract] [Full Text]
Gitiban, N., Jurcisek, J. A., Harris, R. H., Mertz, S. E., Durbin, R. K., Bakaletz, L. O., Durbin, J. E. (2005). Chinchilla and Murine Models of Upper Respiratory Tract Infections with Respiratory Syncytial Virus. J. Virol. 79: 6035-6042 [Abstract] [Full Text]
Williams, A. E., Edwards, L., Humphreys, I. R., Snelgrove, R., Rae, A., Rappuoli, R., Hussell, T. (2004). Innate Imprinting by the Modified Heat-Labile Toxin of Escherichia coli (LTK63) Provides Generic Protection against Lung Infectious Disease. J. Immunol. 173: 7435-7443 [Abstract] [Full Text]
Johnson, T. R., Varga, S. M., Braciale, T. J., Graham, B. S. (2004). V{beta}14+ T Cells Mediate the Vaccine-Enhanced Disease Induced by Immunization with Respiratory Syncytial Virus (RSV) G Glycoprotein but Not with Formalin-Inactivated RSV. J. Virol. 78: 8753-8760 [Abstract] [Full Text]
Heidema, J., de Bree, G. J., de Graaff, P. M. A., van Maren, W. W. C., Hoogerhout, P., Out, T. A., Kimpen, J. L. L., van Bleek, G. M. (2004). Human CD8+ T cell responses against five newly identified respiratory syncytial virus-derived epitopes. J. Gen. Virol. 85: 2365-2374 [Abstract] [Full Text]
Schwarze, J, Schauer, U (2004). Enhanced virulence, airway inflammation and impaired lung function induced by respiratory syncytial virus deficient in secreted G protein. Thorax 59: 517-521 [Abstract] [Full Text]
Chang, J., Choi, S. Y., Jin, H. T., Sung, Y. C., Braciale, T. J. (2004). Improved Effector Activity and Memory CD8 T Cell Development by IL-2 Expression during Experimental Respiratory Syncytial Virus Infection. J. Immunol. 172: 503-508 [Abstract] [Full Text]
Legg, J. P., Hussain, I. R., Warner, J. A., Johnston, S. L., Warner, J. O. (2003). Type 1 and Type 2 Cytokine Imbalance in Acute Respiratory Syncytial Virus Bronchiolitis. Am. J. Respir. Crit. Care Med. 168: 633-639 [Abstract] [Full Text]
Johnson, T. R., Parker, R. A., Johnson, J. E., Graham, B. S. (2003). IL-13 Is Sufficient for Respiratory Syncytial Virus G Glycoprotein-Induced Eosinophilia After Respiratory Syncytial Virus Challenge. J. Immunol. 170: 2037-2045 [Abstract] [Full Text]
van Bleek, G. M., Poelen, M. C., van der Most, R., Brugghe, H. F., Timmermans, H. A. M., Boog, C. J., Hoogerhout, P., Otten, H. G., van Els, C. A. C. M. (2002). Identification of Immunodominant Epitopes Derived from the Respiratory Syncytial Virus Fusion Protein That Are Recognized by Human CD4 T Cells. J. Virol. 77: 980-988 [Abstract] [Full Text]
Culley, F. J., Pollott, J., Openshaw, P. J.M. (2002). Age at First Viral Infection Determines the Pattern of T Cell-mediated Disease during Reinfection in Adulthood. JEM 196: 1381-1386 [Abstract] [Full Text]
Chen, M., Hu, K.-F., Rozell, B., Orvell, C., Morein, B., Liljestrom, P. (2002). Vaccination with Recombinant Alphavirus or Immune-Stimulating Complex Antigen Against Respiratory Syncytial Virus. J. Immunol. 169: 3208-3216 [Abstract] [Full Text]
Plotnicky-Gilquin, H., Cyblat-Chanal, D., Aubry, J.-P., Champion, T., Beck, A., Nguyen, T., Bonnefoy, J.-Y., Corvaia, N. (2002). Gamma Interferon-Dependent Protection of the Mouse Upper Respiratory Tract following Parenteral Immunization with a Respiratory Syncytial Virus G Protein Fragment. J. Virol. 76: 10203-10210 [Abstract] [Full Text]
Papadopoulos, N G, Stanciu, L A, Papi, A, Holgate, S T, Johnston, S L (2002). A defective type 1 response to rhinovirus in atopic asthma. Thorax 57: 328-332 [Abstract] [Full Text]
Johnson, T. R., Hong, S., Van Kaer, L., Koezuka, Y., Graham, B. S. (2002). NK T Cells Contribute to Expansion of CD8+ T Cells and Amplification of Antiviral Immune Responses to Respiratory Syncytial Virus. J. Virol. 76: 4294-4303 [Abstract] [Full Text]
Durbin, J. E., Johnson, T. R., Durbin, R. K., Mertz, S. E., Morotti, R. A., Peebles, R. S., Graham, B. S. (2002). The Role of IFN in Respiratory Syncytial Virus Pathogenesis. J. Immunol. 168: 2944-2952 [Abstract] [Full Text]
Schlender, J., Walliser, G., Fricke, J., Conzelmann, K.-K. (2002). Respiratory Syncytial Virus Fusion Protein Mediates Inhibition of Mitogen-Induced T-Cell Proliferation by Contact. J. Virol. 76: 1163-1170 [Abstract] [Full Text]
Thomas, M. J., Noble, A., Sawicka, E., Askenase, P. W., Kemeny, D. M. (2002). CD8 T Cells Inhibit IgE Via Dendritic Cell IL-12 Induction That Promotes Th1 T Cell Counter-Regulation. J. Immunol. 168: 216-223 [Abstract] [Full Text]
Power, U. F., Huss, T., Michaud, V., Plotnicky-Gilquin, H., Bonnefoy, J.-Y., Nguyen, T. N. (2001). Differential Histopathology and Chemokine Gene Expression in Lung Tissues following Respiratory Syncytial Virus (RSV) Challenge of Formalin-Inactivated RSV- or BBG2Na-Immunized Mice. J. Virol. 75: 12421-12430 [Abstract] [Full Text]
Message, S.D., Johnston, S.L. (2001). The immunology of virus infection in asthma. Eur Respir J 18: 1013-1025 [Abstract] [Full Text]
Ponnuraj, E. M., Hayward, A. R., Raj, A., Wilson, H., Simoes, E. A. F. (2001). Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine. J. Gen. Virol. 82: 2663-2674 [Abstract] [Full Text]
Zhao, M. Q., Amir, M. K., Rice, W. R., Enelow, R. I. (2001). Type II Pneumocyte-CD8+ T-Cell Interactions . Relationship between Target Cell Cytotoxicity and Activation. Am. J. Respir. Cell Mol. Bio. 25: 362-369 [Abstract] [Full Text]
Zhao, M. Q., Foley, M. P., Stoler, M. H., Enelow, R. I. (2001). Alveolar Epithelial Cell Chemokine Expression Induced by Specific Antiviral CD8+ T-Cell Recognition Plays a Critical Role in the Perpetuation of Experimental Interstitial Pneumonia. Chest 120: 11S-13S [Full Text]
Schmidt, A. C., McAuliffe, J. M., Murphy, B. R., Collins, P. L. (2001). Recombinant Bovine/Human Parainfluenza Virus Type 3 (B/HPIV3) Expressing the Respiratory Syncytial Virus (RSV) G and F Proteins Can Be Used To Achieve Simultaneous Mucosal Immunization against RSV and HPIV3. J. Virol. 75: 4594-4603 [Abstract] [Full Text]
Hurst, S. D., Seymour, B. W. P., Muchamuel, T., Kurup, V. P., Coffman, R. L. (2001). Modulation of Inhaled Antigen-Induced IgE Tolerance by Ongoing Th2 Responses in the Lung. J. Immunol. 166: 4922-4930 [Abstract] [Full Text]
Walzl, G., Matthews, S., Kendall, S., Gutierrez-Ramos, J. C., Coyle, A. J., Openshaw, P. J.M., Hussell, T. (2001). Inhibition of T1/ST2 during Respiratory Syncytial Virus Infection Prevents T Helper Cell Type 2 (Th2)- but not Th1-driven Immunopathology. JEM 193: 785-792 [Abstract] [Full Text]
Simmons, C. P., Hussell, T., Sparer, T., Walzl, G., Openshaw, P., Dougan, G. (2001). Mucosal Delivery of a Respiratory Syncytial Virus CTL Peptide with Enterotoxin-Based Adjuvants Elicits Protective, Immunopathogenic, and Immunoregulatory Antiviral CD8+ T Cell Responses. J. Immunol. 166: 1106-1113 [Abstract] [Full Text]
Hussell, T., Openshaw, P. J. M. (2000). IL-12-Activated NK Cells Reduce Lung Eosinophilia to the Attachment Protein of Respiratory Syncytial Virus But Do Not Enhance the Severity of Illness in CD8 T Cell-Immunodeficient Conditions. J. Immunol. 165: 7109-7115 [Abstract] [Full Text]
Varga, S. M., Wissinger, E. L., Braciale, T. J. (2000). The Attachment (G) Glycoprotein of Respiratory Syncytial Virus Contains a Single Immunodominant Epitope That Elicits Both Th1 and Th2 CD4+ T Cell Responses. J. Immunol. 165: 6487-6495 [Abstract] [Full Text]
Hull, J, Thomson, A, Kwiatkowski, D (2000). Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55: 1023-1027 [Abstract] [Full Text]
Walzl, G., Tafuro, S., Moss, P., Openshaw, P. J.M., Hussell, T. (2000). Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus-induced Immunopathology. JEM 192: 1317-1326 [Abstract] [Full Text]
Brandenburg, A. H., de Waal, L., Timmerman, H. H., Hoogerhout, P., de Swart, R. L., Osterhaus, A. D. M. E. (2000). HLA Class I-Restricted Cytotoxic T-Cell Epitopes of the Respiratory Syncytial Virus Fusion Protein. J. Virol. 74: 10240-10244 [Abstract] [Full Text]
Plotnicky-Gilquin, H., Robert, A., Chevalet, L., Haeuw, J.-F., Beck, A., Bonnefoy, J.-Y., Brandt, C., Siegrist, C.-A., Nguyen, T. N., Power, U. F. (2000). CD4+ T-Cell-Mediated Antiviral Protection of the Upper Respiratory Tract in BALB/c Mice following Parenteral Immunization with a Recombinant Respiratory Syncytial Virus G Protein Fragment. J. Virol. 74: 3455-3463 [Abstract] [Full Text]
Zhong, W., Marshall, D., Coleclough, C., Woodland, D. L. (2000). CD4+ T Cell Priming Accelerates the Clearance of Sendai Virus in Mice, but Has a Negative Effect on CD8+ T Cell Memory. J. Immunol. 164: 3274-3282 [Abstract] [Full Text]
Johnson, T. R., Graham, B. S. (1999). Secreted Respiratory Syncytial Virus G Glycoprotein Induces Interleukin-5 (IL-5), IL-13, and Eosinophilia by an IL-4-Independent Mechanism. J. Virol. 73: 8485-8495 [Abstract] [Full Text]
ABERLE, J. H., ABERLE, S. W., DWORZAK, M. N., MANDL, C. W., REBHANDL, W., VOLLNHOFER, G., KUNDI, M., POPOW-KRAUPP, T. (1999). Reduced Interferon-gamma Expression in Peripheral Blood Mononuclear Cells of Infants with Severe Respiratory Syncytial Virus Disease. Am. J. Respir. Crit. Care Med. 160: 1263-1268 [Abstract] [Full Text]
Tripp, R. A., Moore, D., Jones, L., Sullender, W., Winter, J., Anderson, L. J. (1999). Respiratory Syncytial Virus G and/or SH Protein Alters Th1 Cytokines, Natural Killer Cells, and Neutrophils Responding to Pulmonary Infection in BALB/c Mice. J. Virol. 73: 7099-7107 [Abstract] [Full Text]
Srikiatkhachorn, A., Chang, W., Braciale, T. J. (1999). Induction of Th-1 and Th-2 Responses by Respiratory Syncytial Virus Attachment Glycoprotein Is Epitope and Major Histocompatibility Complex Independent. J. Virol. 73: 6590-6597 [Abstract] [Full Text]
Weltzin, R., Monath, T. P. (1999). Intranasal Antibody Prophylaxis for Protection against Viral Disease. Clin. Microbiol. Rev. 12: 383-393 [Abstract] [Full Text]
Schwarze, J., Cieslewicz, G., Joetham, A., Ikemura, T., Hamelmann, E., Gelfand, E. W. (1999). CD8 T Cells Are Essential in the Development of Respiratory Syncytial Virus-Induced Lung Eosinophilia and Airway Hyperresponsiveness. J. Immunol. 162: 4207-4211 [Abstract] [Full Text]
Gern, J. E., Busse, W. W. (1999). Association of Rhinovirus Infections with Asthma. Clin. Microbiol. Rev. 12: 9-18 [Abstract] [Full Text]
Hussell, T., Georgiou, A., Sparer, T. E., Matthews, S., Pala, P., Openshaw, P. J. M. (1998). Host Genetic Determinants of Vaccine-Induced Eosinophilia During Respiratory Syncytial Virus Infection. J. Immunol. 161: 6215-6222 [Abstract] [Full Text]
Tebbey, P. W., Hagen, M., Hancock, G. E. (1998). Atypical Pulmonary Eosinophilia Is Mediated by a Specific Amino Acid Sequence of the Attachment (G) Protein of Respiratory Syncytial Virus. JEM 188: 1967-1972 [Abstract] [Full Text]
Bembridge, G. P., Garcia-Beato, R., Lopez, J. A., Melero, J. A., Taylor, G. (1998). Subcellular Site of Expression and Route of Vaccination Influence Pulmonary Eosinophilia Following Respiratory Syncytial Virus Challenge in BALB/c Mice Sensitized to the Attachment G Protein. J. Immunol. 161: 2473-2480 [Abstract] [Full Text]
Sparer, T. E., Matthews, S., Hussell, T., Rae, A. J., Garcia-Barreno, B., Melero, J. A., Openshaw, P. J.M. (1998). Eliminating a Region of Respiratory Syncytial Virus Attachment Protein Allows Induction of Protective Immunity without Vaccine-enhanced Lung Eosinophilia. JEM 187: 1921-1926 [Abstract] [Full Text]
FOLKERTS, G., BUSSE, W.�W., NIJKAMP, F.�P., SORKNESS, R., GERN, J.�E. (1998). Virus-induced Airway Hyperresponsiveness and Asthma. Am. J. Respir. Crit. Care Med. 157: 1708-1720 [Full Text]
Johnson, T. R., Johnson, J. E., Roberts, S. R., Wertz, G. W., Parker, R. A., Graham, B. S. (1998). Priming with Secreted Glycoprotein G of Respiratory Syncytial Virus (RSV) Augments Interleukin-5 Production and Tissue Eosinophilia after RSV Challenge. J. Virol. 72: 2871-2880 [Abstract] [Full Text]
Andersen, P. (1998). Lung infections bullet �4: Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses. Thorax 53: 302-307 [Full Text]
Chargelegue, D., Obeid, O. E., Hsu, S.-C., Shaw, M. D., Denbury, A. N., Taylor, G., Steward, M. W. (1998). A Peptide Mimic of a Protective Epitope of Respiratory Syncytial Virus Selected from a Combinatorial Library Induces Virus-Neutralizing Antibodies and Reduces Viral Load In Vivo. J. Virol. 72: 2040-2046 [Abstract] [Full Text]
Srikiatkhachorn, A., Braciale, T. J. (1997). Virus-specific CD8+ T Lymphocytes Downregulate T Helper Cell Type 2�Cytokine Secretion and Pulmonary Eosinophilia during Experimental Murine Respiratory Syncytial Virus Infection. JEM 186: 421-432 [Abstract] [Full Text]
ROMN, M., CALHOUN, W.�J., HINTON, K.�L., AVENDAO, L.�F., SIMON, V., ESCOBAR, A.�M., GAGGERO, A., DAZ, P.�V. (1997). Respiratory Syncytial Virus Infection in Infants Is Associated with Predominant Th-2-like Response. Am. J. Respir. Crit. Care Med. 156: 190-195 [Abstract] [Full Text]
Smyth, R L, Fletcher, J N, Thomas, H M, Hart, C A (1997). Immunological responses to respiratory syncytial virus infection in infancy. Arch. Dis. Child. 76: 210-214 [Abstract] [Full Text]
Hall, C. (1994). Prospects for a respiratory syncytial virus vaccine. Science 265: 1393-1394